Download Full Agenda as PDF

Conference Host
Pamala Jacobson, PharmD, FCCP, Organizing Committee Chair

Wednesday, September 21, 2022

Clinical Case Workshop

Pharmacogenomic Cases and Applications to Patient Care

Susie Long, PharmD // M Health Fairview


Pamala Jacobson, PharmD, FCCP // University of Minnesota

9:15-10:00 Case Studies in Mental Health
Tyler Stevens, PharmD // Essentia Health
10:00-10:45 Case Studies in Cardiology
Magali Disdier-Moulder, PharmD // Mayo Clinic
10:45-11:30 Case Studies in Pediatrics
David Gregornik, PharmD, BCOP // Children’s Minnesota
11:30-12:30 Break
12:30-1:15 Case Studies in Oncology
Jai N. Patel, PharmD // Atrium Health
1:15-1:45 Case Studies in Bone Marrow Transplant
Susie Long, PharmD // M Health Fairview
1:45-2:30 Case Studies in NSAIDs and Opioids
Jessica Wright, PharmD // Mayo Clinic
2:30-3:15 Case Studies in PPIs
Valentina Shakhnovich, MD // Children's Mercy Hospital & Clinics, Kansas City
3:15-3:30 Break
3:30-4:15 Case Studies in Pharmacogenomic Assays and Phenotype Calls
Pawel Mroz, MD, PhD // M Health Fairview and University of Minnesota
4:15-5:00 Case Studies in CYP2D6 Phenoconversion
Kelsey Cook, PharmD, BCPS // University of Florida
5:00-5:15 Concluding Remarks
Pamala Jacobson, PharmD, FCCP // University of Minnesota
Thursday, September 22, 2022

Morning Session

The Value Proposition of Pharmacogenomics

David Stenehjem, PharmD, BCOP // University of Minnesota

8:30-9:00 Non-CE Presentation by Geneticure—Lack of Genetic Considerations May be Detrimental to Patients in Current Hypertensive Clinical Recommendations by Eric Snyder, PhD
9:00-9:15 Welcome
9:15-10:15 KEYNOTE ADDRESS | Demonstrating the Economic Value of
Pharmacogenomics in Clinical Care: Moving Beyond Drug-Gene Associations

Peter H. O'Donnell, MD // University of Chicago
10:15-10:45 Breaking the Economic Barrier in Pharmacogenomics
Bijan J. Borah, PhD, MPhil // Mayo Clinic
10:45-11:15 Preventing Harm through Pharmacogenomics
James M. Hoffman, PharmD // St. Jude Children’s Research Hospital
11:15-11:45 Cost of Pharmacogenomic Implementation at System Scale:
Navigating the Financial and Human Investment

Christine Formea, PharmD, BCPS, FCCP, FASHP // Intermountain Healthcare Pharmacy Services
11:45-12:45 Clinical Decision Support for Pharmacogenomics: To Buy or Build?
Panel Discussion
Benjamin Duong, PharmD // Nemours Children's Health
Steven Johnson, PhD // University of Minnesota
Rebecca A. Pulk, PharmD // Yale New Haven Health
12:45-1:15 Non-CE Presentation by OneOme—The Value of Combining PGx with Comprehensive Medication Management (CMM) by Ghada Elnashar, PharmD
1:15-1:45 Non-CE Presentation by Thermo Fisher Scientific—Implement Predictive Genomics Today, Improve Healthcare’s Tomorrow by David Hanna, PhD
1:45-2:15 Pharmacogenomics and the Payer Perspective
Rachael Pearson, PharmD // Optum Genomics at UnitedHealth Group

Afternoon Session

Medication Therapy Management and Pharmacogenomics

Jeffrey Bishop, PharmD, BCPP, FCCP // University of Minnesota

2:15-2:45 Developing CMM/MTM: Get the Medicines Right
Ira Klein, MD, MBA, FACP // GTMRx Institute
2:45-3:45 Pharmacogenomics and MTM: Integration into My Practice—How I Do It
Amina Abubakar, PharmD, AAHIVP // Avant Pharmacy and Wellness
Jennifer (Chi-Fan) Hockings, PharmD, PhD, BCPS // Cleveland Clinic
3:45-4:15 Educating the Patient About Pharmacogenomics and Return of Results
Philip Empey, PharmD, PhD // University of Pittsburgh School of Pharmacy
4:15-4:45 Local Coverage Determinations for Pharmacogenomic Testing and Reimbursement
D. Max Smith, PharmD, BCPS // MedStar Health and Georgetown University School of Medicine
Friday, September 23, 2022

Morning Session

Pharmacogenomics Updates for the Practitioner

Robert J. Straka, PharmD, FCCP // University of Minnesota

8:45-9:00 Welcome
9:00-9:30 The Increased Complexity of Pharmacogenomic Associations: What to Do about Contributions by Multiple Drug-Metabolizing Genes and Pharmacodynamic Genes
Kelly E. Caudle, PharmD, PhD, BCPS, FCCP // St. Jude Children’s Research Hospital
9:30-10:15 Pharmacogenomic Guideline Update: SNRI and SSRI
Jeffrey Bishop, PharmD, BCPP, FCCP // University of Minnesota
10:15-10:45 Pharmacogenomic Guideline Update: Beta Blockers
Julio Duarte, PharmD, PhD, FAHA // University of Florida College of Pharmacy
10:45-11:30 Pharmacogenomic Guideline Update: NSAIDs and Clopidogrel
Craig Lee, PharmD, PhD, FCCP, FAHA // UNC Eshelman School of Pharmacy
11:30-12:00 Pharmacogenomic Guideline Update: Statins
Robert J. Straka, PharmD, FCCP // University of Minnesota
12:00-12:30 Non-CE Presentation by Illumina—Aligning Genomics to Healthcare: Pharmacogenomics by Jamal Mitchell, MS and Adam Hauge, MBA
12:30-1:00 Non-CE Presentation by Invitae—PGx in Practice: Lessons Learned from Pharmacist-Led Implementations by Jennifer Wick, PharmD, MPH, BCACP and Kristine Ashcraft, BS, MBA
1:15-1:45 Novel Education and Implementation Strategies in Pharmacogenomics
David Stenehjem, PharmD, BCOP // University of Minnesota
1:45-2:15 Regulatory Issues Relevant to Pharmacogenomics
Josiah Allen, PharmD // St. Elizabeth Healthcare
2:15-2:45 Development of a Telehealth Program for Pharmacogenomics
Jonathan Neufeld, PhD // Great Plains Telehealth Resource and Assistance Center
2:45-3:15 Legal and Liability Implications of Pharmacogenomics for Physicians and Pharmacists
Anthony P. Morreale, PharmD // Department of Veterans Affairs

Afternoon Session

Pharmacogenomics in Underserved Populations

Josiah Allen, PharmD // St. Elizabeth Healthcare

3:45-4:15 Pharmacogenomic Implementation in Rural and Underserved Populations: Challenges and Solutions
Erica Woodahl, PhD // University of Montana
4:15-4:45 Moving Beyond Eurocentric Pharmacogenetics to Improve Health Outcomes for All
Akinyemi Oni-Orisan, PharmD, PhD, DABCP, CLS, AACC // University of California, San Francisco
4:45-5:00 Conclusion of Program
Pamala Jacobson, PharmD, FCCP // University of Minnesota